These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34563736)

  • 1. Anti-Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry.
    Graff S; Brusselle G; Hanon S; Sohy C; Dupont L; Peche R; Michils A; Pilette C; Joos G; Lahousse L; Lapperre T; Louis R; Schleich F
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):467-477. PubMed ID: 34563736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma.
    Graff S; Demarche S; Henket M; Paulus V; Louis R; Schleich F
    Respir Med; 2019 Jun; 152():60-66. PubMed ID: 31128611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilation Test with Inhaled Salbutamol Versus Bronchial Methacholine Challenge to Make an Asthma Diagnosis: Do They Provide the Same Information?
    Louis R; Bougard N; Guissard F; Paulus V; Henket M; Schleich F
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):618-625.e8. PubMed ID: 31541767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline.
    Matsunaga K; Ichikawa T; Oka A; Morishita Y; Kanai K; Hiramatsu M; Akamatsu H; Kawabata H; Kikuchi T; Akamatsu K; Hirano T; Kou Y; Nakanishi M; Minakata Y; Yamamoto N
    Respir Med; 2014 Jul; 108(7):976-82. PubMed ID: 24856920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma.
    Sposato B; Scalese M; Ricci A; Rogliani P; Paggiaro P;
    Clin Respir J; 2021 Feb; 15(2):237-243. PubMed ID: 33400385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.
    Crimi C; Campisi R; Cacopardo G; Intravaia R; Nolasco S; Porto M; Pelaia C; Crimi N
    World Allergy Organ J; 2020 Sep; 13(9):100462. PubMed ID: 32994855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials.
    Lemiere C; Taillé C; Lee JK; Smith SG; Mallett S; Albers FC; Bradford ES; Yancey SW; Liu MC
    Respir Res; 2021 Jun; 22(1):184. PubMed ID: 34158028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).
    Schleich F; Brusselle G; Louis R; Vandenplas O; Michils A; Pilette C; Peche R; Manise M; Joos G
    Respir Med; 2014 Dec; 108(12):1723-32. PubMed ID: 25456708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study.
    Abdo M; Watz H; Veith V; Kirsten AM; Biller H; Pedersen F; von Mutius E; Kopp MV; Hansen G; Waschki B; Rabe KF; Trinkmann F; Bahmer T
    Respir Res; 2020 Oct; 21(1):278. PubMed ID: 33087134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial CD8 cell infiltrate and lung function decline in asthma.
    van Rensen EL; Sont JK; Evertse CE; Willems LN; Mauad T; Hiemstra PS; Sterk PJ;
    Am J Respir Crit Care Med; 2005 Oct; 172(7):837-41. PubMed ID: 16085937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FEV
    Backman H; Lindberg A; Hedman L; Stridsman C; Jansson SA; Sandström T; Lundbäck B; Rönmark E
    World Allergy Organ J; 2020 Mar; 13(3):100110. PubMed ID: 32206161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety.
    van Toor JJ; van der Mark SC; Kappen JH; In 't Veen JCCM; Braunstahl GJ
    J Asthma; 2021 May; 58(5):651-658. PubMed ID: 31999203
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma.
    Ortega H; Yancey SW; Keene ON; Gunsoy NB; Albers FC; Howarth PH
    J Allergy Clin Immunol Pract; 2018; 6(3):980-986.e1. PubMed ID: 29398640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups.
    Overbeek SE; Kerstjens HA; Bogaard JM; Mulder PG; Postma DS
    Chest; 1996 Jul; 110(1):35-41. PubMed ID: 8681660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP).
    Zeiger RS; Dawson C; Weiss S
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):376-87. PubMed ID: 10069869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
    Liu MC; Chipps B; Munoz X; Devouassoux G; Bergna M; Smith SG; Price RG; Galkin DV; Azmi J; Mouneimne D; Albers FC; Chapman KR
    Respir Res; 2021 May; 22(1):144. PubMed ID: 33971856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline.
    Marc-Malovrh M; Camlek L; Škrgat S; Kern I; Fležar M; Dežman M; Korošec P
    Respir Med; 2020 Feb; 162():105875. PubMed ID: 32056673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype.
    Pelaia C; Crimi C; Pelaia G; Nolasco S; Campisi R; Heffler E; Valenti G; Crimi N
    Clin Exp Allergy; 2020 Jul; 50(7):780-788. PubMed ID: 32347992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.